ALLMedicine™ Gastric Cancer Center
Research & Reviews 17,918 results
https://doi.org/10.1007/s12032-023-01990-2
Medical Oncology (Northwood, London, England); Zhu Y, Yang J et. al.
Mar 28th, 2023 - Enhanced expression of fat mass and obesity-associated protein (FTO) has been reported in gastric cancer (GC). Bioinformatical studies indicate that FTO expression is correlated with the patients' overall survival (OS). How FTO exerts its promotio...
https://doi.org/10.1111/imcb.12641
Immunology and Cell Biology; Dawson RE, Deswaerte V et. al.
Mar 28th, 2023 - Helicobacter pylori (H. pylori) infection can trigger chronic gastric inflammation perpetuated by overactivation of the innate immune system, leading to a cascade of precancerous lesions culminating in gastric cancer (GC). However, key regulators ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037253
World Journal of Gastroenterology; Mao LT, Chen WC et. al.
Mar 28th, 2023 - The level of Ki-67 expression has served as a prognostic factor in gastric cancer. The quantitative parameters based on the novel dual-layer spectral detector computed tomography (DLSDCT) in discriminating the Ki-67 expression status are unclear. ...
https://doi.org/10.1093/bjs/znad065
The British Journal of Surgery; Pucher PH, Park MH et. al.
Mar 28th, 2023 - The National Oesophago-Gastric Cancer Audit (NOGCA) captures patient data from diagnosis to end of primary treatment for all patients with oesophagogastric (OG) cancer in England and Wales. This study assessed changes in patient characteristics, t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038735
Canadian Journal of Gastroenterology & Hepatology; Qiu P, Li X et. al.
Mar 28th, 2023 - Gastric cancer (GC) is a common digestive tract malignancy worldwide. N-myristoyltransferase 1 (NMT1) has been implicated in many cancers, but its association with gastric cancer remains to be clarified. Thus, this paper elucidated the role of NMT...
Guidelines 25 results
https://doi.org/10.1016/j.annonc.2022.07.004
Annals of Oncology : Official Journal of the European Soc... Lordick F, Carneiro F et. al.
Aug 2nd, 2022 - Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.|2022|Lordick F,Carneiro F,Cascinu S,Fleitas T,Haustermans K,|diagnosis,epidemiology,therapy,
https://doi.org/10.6004/jnccn.2022.0008
Journal of the National Comprehensive Cancer Network : JN... Ajani JA, D'Amico TA et. al.
Feb 8th, 2022 - Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic location and histologic type. Gastric cancer generally carries a poor p...
https://doi.org/10.1016/j.jacr.2021.08.006
Journal of the American College of Radiology : JACR; , Vij A et. al.
Nov 20th, 2021 - Epigastric pain can have multiple etiologies including myocardial infarction, pancreatitis, acute aortic syndromes, gastroesophageal reflux disease, esophagitis, peptic ulcer disease, gastritis, duodenal ulcer disease, gastric cancer, and hiatal h...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740554
Gastroenterology Shah SC, Piazuelo MB et. al.
Aug 30th, 2021 - The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis du...
https://doi.org/10.6004/jnccn.2021.0001
Journal of the National Comprehensive Cancer Network : JN... Daly MB, Pal T et. al.
Jan 7th, 2021 - The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic focus primarily on assessment of pathogenic or likely pathogenic variants associated with increased risk of breast, ovarian, and pancreatic cancer and r...
Drugs 4 results see all →
Clinicaltrials.gov 1,848 results
https://clinicaltrials.gov/ct2/show/NCT04487717
Mar 23rd, 2023 - Background: According to Global Cancer Statistics of International Agency for Research on Cancer under World Health Organization, stomach cancer is the fifth most common cancer as there were over 1 million new cases in 2018 and the third leading c...
https://clinicaltrials.gov/ct2/show/NCT04535414
Mar 23rd, 2023 - Background: Hereditary Diffuse Gastric Cancer (HDGC) is most often attributed to inactivating germline mutations in the E-cadherin (CDH1) tumor suppressor gene. Mutation carriers have a 24-70% lifetime risk of developing gastric adenocarcinoma. In...
https://clinicaltrials.gov/ct2/show/NCT01928394
Mar 21st, 2023 - All tumor types are now closed for enrollment: Triple Negative Breast Cancer Gastric Cancer Pancreatic Cancer Small Cell Lung Cancer Bladder Cancer Ovarian Cancer
https://clinicaltrials.gov/ct2/show/NCT05280665
Mar 21st, 2023 - Specialization is having sufficient and effective knowledge on a subject. Today, in the medical world, specialization is defined as having competent knowledge on a disease, and in recent years, the benefit of specialization has begun to be emphasi...
https://clinicaltrials.gov/ct2/show/NCT01968109
Mar 17th, 2023 - The purpose of the study is to assess the safety, tolerability and effectiveness of experimental medication BMS-986016 administered alone and in combination with nivolumab in patients with solid tumors that have spread and/or cannot be removed by ...
News 1,424 results
https://www.medpagetoday.com/hematologyoncology/othercancers/103538
Mar 15th, 2023 - Relapse-free survival (RFS) data at 5 years showed that laparoscopy-assisted distal gastrectomy (LADG) was noninferior to open distal gastrectomy (ODG) in locally advanced gastric cancer, according to a phase II/III randomized trial from Japan. Am...
https://www.medpagetoday.com/hematologyoncology/othercancers/102596
Jan 11th, 2023 - Almost one-third of patients undergoing omentectomy for peritoneal metastases had occult omental metastases, supporting routine omentectomy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC), authors of a retr...
https://www.medpagetoday.com/endocrinology/obesity/102587
Jan 11th, 2023 - Undergoing bariatric surgery for severe obesity was linked to a decreased incidence of esophageal and gastric cancer and overall in-hospital mortality, a French cohort study showed. Among mostly women, the incidence rates of these cancers were 4.9...
https://www.medscape.com/viewarticle/969537
Dec 13th, 2022 - This transcript has been edited for clarity. Jacob Sands, MD: I'm Dr Jacob Sands, thoracic medical oncologist at the Dana-Farber Cancer Institute. Welcome to Medscape's InDiscussion series on lung cancer. Today, we'll be discussing disparities in ...
https://www.onclive.com/view/frontline-pembrolizumab-plus-chemotherapy-meets-os-end-point-in-her2-negative-gastric-gej-adenocarcinoma
Nov 22nd, 2022 - The combination of pembrolizumab (Keytruda) and physician’s choice of chemotherapy produced a statistically significant overall survival (OS) benefit vs chemotherapy plus placebo in patients with HER2-negative, locally advanced, unresectable or me...